GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45
GENTAUR U.S.A Genprice Inc 6017 Snell Ave, Ste 357, SanJose, CA 95123
Tel (408) 780-0908, Fax (408) 780-0908, email@example.com
Product name : Boc_Ile
Catalog number : 2065
Supplier name : Sceti K.K.
Data sheet: Ask more or other datasheet now !
More Details about
Human sera, especially from patients with autoimmune diseases, contain high levels of immunoreactive components, which yield high background levels in ELISA systems. These non-specific reactions are caused by adhesive immunoglobulins contained in human serum, which strongly adhere to plastic surfaces by hydrophilic binding, and blocking agents such as bovine serum albumin (BSA) and Tween 20, are not capable of blocking these non-specific reactions at all. However, these false positive reactions caused by serum sample itself have not been understood, and are considered as a real antibodyantigen reaction in many cases, even now. In order to obtain a real value of antigen-antibody reaction, it is critical 1) to choose proper blocking agents which block these kinds of non-specific reactions effectively, 2) to determine a unique non-specific background value of individual samples using antigen-non-coated wells and 3) to subtract the background value from the value determined in antigen-coated wells. In addition, it is apparent to determine the non-specific reactions caused by secondary antibody as well. Chondrex’s ELISA system incorporates unique blocking agents that inhibit the hydrophobic binding of these serum components onto plastic surfaces and are designed
to determine the background values of individual samples using antigen-non-coated wells.
IgA antibodies to type II collagen are often associated with IgG antibodies in human sera. Importantly, IgA and IgG antibodies share identical collagen types and species specificity in individual sera, suggesting that the same collagen is involved in eliciting these antibodies. Therefore, it is highly likely that heterologous collagen in diets may play a primary role in the anti-collagen antibody production, regardless of the disease.
However, this does not indicate that only type II collagen is always the eliciting antigen, since type I collagen, found abundantly in diets, share amino acid sequences with type II collagen by more than 80% and the antibodies in human sera often react to both type I and type II collagen.
To determine the diversity of anti-collagen antibodies in human sera, Chondrex provides IgA and IgG antibody assay kits with various species of type I and type II collagen-coated strips as well as uncoated wells (see table above). This ELISA kit contains enough materials to run two plates on two separate occasions (see assay procedure) and may be used for monkey sera as well as human sera.
Note: Since IgA and IgG antibodies in human sera share similar collagen types and species of specificity, it is assumed that IgA antibodies determined by this ELISA kit might be underestimated due to the competitive binding of IgG antibodies to the identical epitopes on collagen molecules. In order to determine accurate IgA antibody levels in human serum samples, it is recommended to treat serum samples with Protein G to remove IgG antibodies.
NOTES BEFORE USING ASSAY
Note 1: It is recommended that the standard and samples be run in duplicate.
Note 2: Partially used reagents may be kept at –20°C.
Note 3: Crystals may form in the 20X wash buffer when stored at cold temperatures. If crystals have formed, it is necessary to warm the wash buffer by placing the bottle in warm water until crystals have dissolved completely.
Note 4: Measure exact volume of buffers using a serological pipette prior to diluting. Extra buffer is provided.
1. Dilute Wash Buffer: Dilute 50 mL of 20X wash buffer in 950 mL of distilled water (1X wash buffer). Wash the plate with 1X wash buffer at least 3 times using a wash bottle with manifold or an automated plate washer. Empty the plate by inverting it and blot on a paper towel to remove excess liquid. Do not allow the plate to dry out.
2. Add Blocking Buffer: Add 100 mL of Blocking Buffer (Solution A) to all wells. Incubate for 1 hour at room temperature.
3. Prepare Standard Dilutions: Undiluted standard is 16 units/mL. Prepare serial dilutions of the standard by mixing 250 mL of 16 units/mL standard with 250 mL of Sample/Standard Dilution Buffer (Solution B) - 8 units/mL . Then repeat this procedure to make five more serial dilutions of standard - 4, 2, 1, 0.5 and 0.25 units/mL solutions. The 16 units/mL standard may be stored at -20°C for use
in a second assay. We recommend making fresh serial dilutions for each assay.
4. Prepare Sample Dilutions: Dilute samples 1:100 or more with Solution B. For example, dilute 20 mL of sample with 1.98 mL of Solution B (1:100). Keep this as a stock solution for future assays. If necessary, dilute the samples further with Solution B, 1:200-1:1000.
Note: Human serum samples have a high lipid content in general. In order to avoid non-specific reactions caused by lipids, centrifuge samples at 10,000 rpm for 5 minutes using a tabletop centrifuge. Take a desired volume of serum sample carefully by pipette and then wipe the pipette surface with paper.
5. Wash: Wash the plate with 1X wash buffer at least 3 times using a wash bottle with manifold or an automated plate washer. Empty the plate by inverting it and blot on a paper towel to remove excess liquid. Do not allow the plate to dry out.
6. Add Standards and Samples: Add 100 mL of standards, Solution B (blank), and samples to collagen coated and uncoated wells in duplicate. Incubate at 4°C overnight.
7. Wash: Wash the plate with 1X wash buffer at least 3 times using a wash bottle with manifold or an automated plate washer. Empty the plate by inverting it and blot on a paper towel to remove excess liquid. Do not allow the plate to dry out.
8. Add Secondary Antibody: Dissolve one vial of secondary antibody in 10 mL Secondary Antibody Dilution Buffer (Solution C1).
Add 100 mL of secondary antibody solution to each well and incubate at room temperature for 2 hours.
9. Wash: Wash the plate with 1X wash buffer at least 3 times using a wash bottle with manifold or an automated plate washer. Empty the plate by inverting it and blot on a paper towel to remove excess liquid. Do not allow the plate to dry out.
10. Add Streptavidin Peroxidase: Dilute one vial of Streptavidin Peroxidase in 10 mL of Streptavidin Peroxidase Dilution Buffer (Solution C2). Add 100 mL of streptavidin peroxidase solution to each well and incubate at room temperature for 1 hour.
11 . Wash: Wash the plate with 1X wash buffer at least 3 times using a wash bottle with manifold or an automated plate washer. Empty the plate by inverting it and blot on a paper towel to remove excess liquid. Do not allow the plate to dry out.
12. OPD: Dissolve one vial of OPD in 10 mL of OPD Dilution Buffer just prior to use. Add 100 mL of OPD solution to each well immediately after washing the plate. Incubate for 30 minutes at room temperature.
13. Stop: Add 50 mL of 2N sulfuric acid (Stop Solution) to each well.
14. Read Plate: Read the OD values at 490 nm. If the OD values of samples are greater than the OD values of the highest standard, re-assay the samples at a higher dilution. A 630 nm filter can be used as a reference.
CALCULATION OF ANTIBODY TITERS
1. Average the duplicate OD values for the standards, blanks (B) and test samples in uncoated wells and collagen coated wells.
2. Subtract the blank (B) values from the averaged OD values of the standards and test samples in uncoated wells and collagen coated wells.
Note: Individual antigens have unique background values. Therefore, blank wells should be used for each different antigen.
3. Subtract the OD values of samples tested in uncoated wells (background values) from their counterpart OD values in collagen coated wells from step 2 to eliminate values associated with non-specific reactions.
4. Plot the OD values of standards against the units/mL of antibody standard. Using a log/log plot will linearize the data. Figure 3 shows a representative experiment where the standard range is from 0.25 to 16 units/mL.
5. The units/mL of antibody in test samples can be calculated using regression analysis.
Contact us about this product :
Our team will respond you as soon as possible !
52062 Aachen Deutschland
Support Karolina Elandt
Fax: (+49) 241 56 00 47 88
Logistic :0241 40 08 90 86
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
firstname.lastname@example.org | Gentaur
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123
Canada Montreal +15149077481
Ceská republika Praha +420246019719
Finland Helsset +358942419041
Magyarország Budapest +3619980547
US New York+17185132983
No related Items
Related Genes :
[TP53 P53] Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53)
[Boc] Brother of CDO (Protein BOC)
[BOC UNQ604/PRO1190] Brother of CDO (Protein BOC)
[SCN5A] Sodium channel protein type 5 subunit alpha (HH1) (Sodium channel protein cardiac muscle subunit alpha) (Sodium channel protein type V subunit alpha) (Voltage-gated sodium channel subunit alpha Nav1.5)
[SHH] Sonic hedgehog protein (SHH) (HHG-1) [Cleaved into: Sonic hedgehog protein N-product; Sonic hedgehog protein C-product]
[SCN1A NAC1 SCN1] Sodium channel protein type 1 subunit alpha (Sodium channel protein brain I subunit alpha) (Sodium channel protein type I subunit alpha) (Voltage-gated sodium channel subunit alpha Nav1.1)
[F8 F8C] Coagulation factor VIII (Antihemophilic factor) (AHF) (Procoagulant component) [Cleaved into: Factor VIIIa heavy chain, 200 kDa isoform; Factor VIIIa heavy chain, 92 kDa isoform; Factor VIII B chain; Factor VIIIa light chain]
[TTN] Titin (EC 18.104.22.168) (Connectin) (Rhabdomyosarcoma antigen MU-RMS-40.14)
[Shh Hhg1] Sonic hedgehog protein (SHH) (HHG-1) [Cleaved into: Sonic hedgehog protein N-product (Sonic hedgehog protein 19 kDa product); Sonic hedgehog protein C-product (Sonic hedgehog protein 27 kDa product)]
[BRCA1 RNF53] Breast cancer type 1 susceptibility protein (EC 6.3.2.-) (RING finger protein 53)
[FBN1 FBN] Fibrillin-1 [Cleaved into: Asprosin]
[ATP7B PWD WC1 WND] Copper-transporting ATPase 2 (EC 22.214.171.124) (Copper pump 2) (Wilson disease-associated protein) [Cleaved into: WND/140 kDa]
[PRSS1 TRP1 TRY1 TRYP1] Trypsin-1 (EC 126.96.36.199) (Beta-trypsin) (Cationic trypsinogen) (Serine protease 1) (Trypsin I) [Cleaved into: Alpha-trypsin chain 1; Alpha-trypsin chain 2]
[ATM] Serine-protein kinase ATM (EC 188.8.131.52) (Ataxia telangiectasia mutated) (A-T mutated)
[APP A4 AD1] Amyloid beta A4 protein (ABPP) (APPI) (APP) (Alzheimer disease amyloid protein) (Amyloid precursor protein) (Beta-amyloid precursor protein) (Cerebral vascular amyloid peptide) (CVAP) (PreA4) (Protease nexin-II) (PN-II) [Cleaved into: N-APP; Soluble APP-alpha (S-APP-alpha); Soluble APP-beta (S-APP-beta); C99; Beta-amyloid protein 42 (Beta-APP42); Beta-amyloid protein 40 (Beta-APP40); C83; P3(42); P3(40); C80; Gamma-secretase C-terminal fragment 59 (Amyloid intracellular domain 59) (AICD-59) (AID(59)) (Gamma-CTF(59)); Gamma-secretase C-terminal fragment 57 (Amyloid intracellular domain 57) (AICD-57) (AID(57)) (Gamma-CTF(57)); Gamma-secretase C-terminal fragment 50 (Amyloid intracellular domain 50) (AICD-50) (AID(50)) (Gamma-CTF(50)); C31]
[KCNQ1 KCNA8 KCNA9 KVLQT1] Potassium voltage-gated channel subfamily KQT member 1 (IKs producing slow voltage-gated potassium channel subunit alpha KvLQT1) (KQT-like 1) (Voltage-gated potassium channel subunit Kv7.1)
[KCNH2 ERG ERG1 HERG] Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1)
[EGFR ERBB ERBB1 HER1] Epidermal growth factor receptor (EC 184.108.40.206) (Proto-oncogene c-ErbB-1) (Receptor tyrosine-protein kinase erbB-1)
[MSH2] DNA mismatch repair protein Msh2 (hMSH2) (MutS protein homolog 2)
[KNG1 BDK KNG] Kininogen-1 (Alpha-2-thiol proteinase inhibitor) (Fitzgerald factor) (High molecular weight kininogen) (HMWK) (Williams-Fitzgerald-Flaujeac factor) [Cleaved into: Kininogen-1 heavy chain; T-kinin (Ile-Ser-Bradykinin); Bradykinin (Kallidin I); Lysyl-bradykinin (Kallidin II); Kininogen-1 light chain; Low molecular weight growth-promoting factor]
[BRCA2 FACD FANCD1] Breast cancer type 2 susceptibility protein (Fanconi anemia group D1 protein)
[NPC1] Niemann-Pick C1 protein
[ABCA4 ABCR] Retinal-specific ATP-binding cassette transporter (ATP-binding cassette sub-family A member 4) (RIM ABC transporter) (RIM protein) (RmP) (Stargardt disease protein)
[GJB1 CX32] Gap junction beta-1 protein (Connexin-32) (Cx32) (GAP junction 28 kDa liver protein)
[PKD1] Polycystin-1 (Autosomal dominant polycystic kidney disease 1 protein)
[MET] Hepatocyte growth factor receptor (HGF receptor) (EC 220.127.116.11) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met)
[GAA] Lysosomal alpha-glucosidase (EC 18.104.22.168) (Acid maltase) (Aglucosidase alfa) [Cleaved into: 76 kDa lysosomal alpha-glucosidase; 70 kDa lysosomal alpha-glucosidase]
[PTEN MMAC1 TEP1] Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN (EC 22.214.171.124) (EC 126.96.36.199) (EC 188.8.131.52) (Mutated in multiple advanced cancers 1) (Phosphatase and tensin homolog)
[RYR1 RYDR] Ryanodine receptor 1 (RYR-1) (RyR1) (Skeletal muscle calcium release channel) (Skeletal muscle ryanodine receptor) (Skeletal muscle-type ryanodine receptor) (Type 1 ryanodine receptor)
[AR DHTR NR3C4] Androgen receptor (Dihydrotestosterone receptor) (Nuclear receptor subfamily 3 group C member 4)
Enter catalog number :